Video

Q&A With Diego Cadavid, MD, FAAN, of Biogen: Anti-Lingo-1 for Optic Neuritis Treatment

Author(s):

As one of the first signs of multiple sclerosis acute optic neuritis can be a worrying symptom for patients. Finding the proper treatment can be important in the early stages of diagnosis.

As one of the first signs of multiple sclerosis acute optic neuritis can be a worrying symptom for patients. Finding the proper treatment can be important in the early stages of diagnosis.

Diego Cadavid, MD, FAAN, from Biogen International discussed the effects of Anti-LINGO-1 in the treatment of Acute Optic Neuritis and the results of the RENEW Trial during the American Academy of Neurology's annual meeting in Washington DC.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
© 2024 MJH Life Sciences

All rights reserved.